Related Experiment Video
Updated: May 11, 2025
07:15
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.6K
101 Machine Learning Algorithms for Mining Esophageal Squamous Cell Carcinoma Neoantigen Prognostic Models in
Yingjie Sun1, Yuheng Tang1, Qi Qi1
1Laboratory of Molecular Genetics of Aging & Tumor, Medicine School, Kunming University of Science and Technology, No. 727, Jingming South Road, Kunming 650500, China.
International Journal of Molecular Sciences
|April 17, 2025
Summary
Researchers developed a novel five-gene prognostic model for esophageal squamous cell carcinoma (ESCC) to predict immunotherapy response. This model aids in understanding immune evasion and identifying new therapeutic targets for this aggressive cancer.
Area of Science:
- Oncology
- Immunotherapy
- Bioinformatics
Background:
- Esophageal squamous cell carcinoma (ESCC) is an aggressive digestive tract cancer with high recurrence rates.
- Current immunotherapy options for ESCC are limited, necessitating novel treatment strategies.
Purpose of the Study:
- To develop a prognostic model for ESCC using machine learning.
- To evaluate the model's correlation with antigen-presenting cells (APCs) and immune infiltration.
- To identify potential therapeutic targets and small-molecule compounds for ESCC treatment.
Main Methods:
- Analysis of ESCC mutation data from public databases.
- Application of 10 machine learning algorithms to generate 101 combinations.
- Construction of a five-gene prognostic model (DLX5, MAGEA4, PMEPA1, RCN1, TIMP1).
- Validation of the model's correlation with APCs and analysis of immune evasion mechanisms.
Main Results:
- A five-gene prognostic model was established, demonstrating correlation with antigen presentation efficacy.
- Mechanisms of immune evasion in ESCC were elucidated.
- The impact of prognostic genes on ESCC progression was examined.
- Potential anti-tumor small-molecule compounds targeting these genes were identified.
Conclusions:
- The developed neoantigen-based prognostic model can predict immunotherapy response in ESCC patients.
- This study provides insights into the tumor microenvironment and antigen presentation in ESCC.
- The findings suggest novel therapeutic targets for improving ESCC treatment strategies.
